Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;45:b3-b5

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

(Hypertension. 2005;45:b3.)
© 2005 American Heart Association, Inc.

Meetings Calendar


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

AHA Meetings

These meetings are sponsored by the American Heart Association and its scientific councils. For information, contact the AHA, Scientific Meetings, 7272 Greenville Ave, Dallas, TX 75231-4596; Fax 214-373-3406; E-mail scientificconferences@heart.org or Web site http://my.americanheart.org/portal/professional/conferencesevents

2005

Feb 2–4: International Stroke Conference 2005. New Orleans, La. The International Stroke Conference encompasses 21/2 days of educational forums highlighting recent advances in the treatment, prevention and outcomes of cerebrovascular disease and stroke. More than 450 posters and oral presentations and lectures will be featured. Special symposia this year will focus on several topics, including: the impact of hypertension, hyperglycemia, and hyperthermia in the acute phase of stroke; novel interventions for the treatment of intracranial aneurysms; evolving approaches to treat intracranial hemorrhage; use of ultrasounds as an acute treatment for stroke; translational research in nursing; primary prevention for stroke; stroke and sleep disturbances; telemedicine and stroke; and more. Sessions from the clinical categories include diagnosis, acute management, in-hospital treatment, rehabilitation and recovery, prevention and community/risk factors, and outcomes. Experimental categories include neurons/glia/inflammation and vascular pathophysiology/thrombosis. For more information, see http://strokeconference.americanheart.org.

Feb 16–19: 2nd International Conference on Women, Heart Disease and Stroke. Orlando, Fla. The conference is jointly sponsored by the American Heart Association, the Centers for Disease Control and Prevention, the American College of Cardiology Foundation, the World Heart Federation, the National Heart, Lung, and Blood Institute, and the Heart and Stroke Foundation of Canada. This 21/2-day program will present plenary and concurrent oral and poster sessions that will explore the reasons for the disturbing . . . [Full Text of this Article]